Browse > Article

Clinical Results of Pulmonary Resection for Hemoptysis of Inflammatory Lung Disease  

Kim Nan Yeol (Department of Thoracic and Cardiovascular Surgery, Chonbuk National University Medical School)
Kuh Ja Hong (Department of Thoracic and Cardiovascular Surgery, Chonbuk National University Medical School)
Kim Min Ho (Department of Thoracic and Cardiovascular Surgery, Chonbuk National University Medical School)
Seo Yeon Ho (Department of Thoracic and Cardiovascular Surgery, Chonbuk National University Medical School)
Publication Information
Journal of Chest Surgery / v.38, no.10, 2005 , pp. 705-709 More about this Journal
Abstract
Background: To assess the outcome of pulmonary resection in the management of hemoptysis caused by benign inflammatory lung disease. Material and Method: A longitudinal cohort study of 45 consecutive patients who were presented with hemoptysis and were treated with pulmonary resection from January 1995 to May 2004. The predictive preoperative risk factors of morbidity and recurrence of hemoptysis were analyzed. The mean age of the patients was 47.1 years. The mean follow-up was $35\pm34$ months. Result: The overall hospital mortality rate was $4.4\%(2/45)$. Postoperative complications occurred in 8 patients $(18.6\%)$. Complications were more common in patients who received blood transfusion than non-transfused patients (p=0.002). Patients with tuberculous destroyed lung disease had more amount of preoperative hemoptysis (p=0.002), more probability of transfusion (p=0.001), more probability of undergoing pneumonectomy (p=0.039) and more probability of postoperative morbidity. Patients of undergoing pneumonectomy had more probability of reoperation due to postoperative bleeding (p=0.047). Hemoptysis recurred in five patients but three had been subsided and two sustained during follow-up. A latter two patients had been prescribed with antituberculosis medication due to relapse of tuberculosis. Conclusion: A tuberculous destroyed lung disease has a higher rate of postoperative morbidity than other inflammatory lung diseases. A pneumonectomy in patients of inflammatory lung disease should be performed with great caution especially because of postoperative bleeding. Future study with longer and larger follow-up might show the reasons of recurrence of hemoptysis.
Keywords
Lung surgery; Morbidity; Lung infection; Hemoptysis;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Knott-Craig CJ, Oostuizen JG, Rossouw G, Joubert JR, Barnard PM. Management and prognosis of massive hemoptysis. J Thorac Cardiovasc Surg 1993;105:394-7
2 Ayed A. Pulmonary resection for massive hemoptysis of benign etiology. Eur J Cardiothorac Surg 2003;24:689-93   DOI   ScienceOn
3 Lee HR, Chung HK. Surgical evaluation of hemoptysis patients. Korean J Thorac Cardiovasc Surg 1987;20:128-38
4 Conlan AA, Hurwitz SS, Krige L, Nicolaou N, Pool R. Massive hemoptysis. J Thorac Cardiovasc Surg 1983;85:120- 4
5 Fidan A, Ozdogan S, Oruc O, et al. Hemoptysis: a retrospective analysis of 108 cases. Respir Med 2002;96:677-80   DOI   ScienceOn
6 Swanson KL, Johnson CM, Prakash UBS, McKusick MA, Andrews JC, Stanson AW. Bronchial artery embolization. Chest 2002;121:789-95   DOI   ScienceOn
7 Jean-Baptiste E. Clinical assessment and management of massive hemoptysis. Crit Care Med 2000;28:1642-7   DOI   PUBMED   ScienceOn
8 Garzon AA, Cerruti MM, Golding ME. Exsanguinating hemoptysis. J Thorac Cardiovasc Surg 1982;84:829-33
9 Thompson AB, Teschler H, Rennard SI. Pathogenesis, evaluation, and therapy for massive hemoptysis. Clin Chest Med 1992;13:69-82
10 Keller FS, Rosch J, Loflin TG, Nath PH, McElvein RB. Nonbronchial systemic collateral arteries: significance in percutaneous embolotherapy for hemoptysis. Radiology 1987; 164:687-92
11 Endo S, Otani S, Saito N, et al. Management of massive hemoptysis in a thoracic surgical unit. Eur J Cardiothorac Surg 2003;23:467-72   DOI   ScienceOn
12 Kim HK, Oh JH, Lee CK, et al. Clinical evaluation of hemoptysis. Korean J Thorac Cardiovasc Surg 1994;27:36-42